Form 4: Metagenomi CFO Sells Shares
Insider Transaction (Form 4)
Pamela Wapnick, Chief Financial Officer of Metagenomi, Inc., sold 1,911 shares of common stock on September 8, 2026 for $1.16 per share.
Summary
- Open-market sale: disposed of 1,911 Common Stock at $1.16 ($2,214) on September 8, 2026; holds 206,580 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $2,214 of stock on the open market.
Insider Transactions
Pamela Wapnick — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-08 | Open-market sale | Common Stock | 1,911 | $1 | $2.2K | 206,580 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-08 | Open-market sale (1,911 shares) |
Keywords
insider transaction, Form 4, MGX, Metagenomi Therapeutics, Inc., bearish, Pamela Wapnick
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.